These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9084967)

  • 21. Pharmacometrics-guided drug development of antihyperhidrosis agents.
    Mehrotra S; Schmith VD; Dumitrescu TP; Gobburu J
    J Clin Pharmacol; 2015 Nov; 55(11):1256-67. PubMed ID: 25939678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of topical glycopyrrolate in Ross syndrome.
    Bajaj V; Haniffa M; Reynolds NJ
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S111-2. PubMed ID: 17052524
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic Hotline: Topical glycopyrrolate: a successful treatment for craniofacial hyperhidrosis and eccrine hidrocystomas.
    Garnacho Saucedo GM; Moreno Jiménez JC; Jiménez Puya R; Rodríguez Bujaldon A
    Dermatol Ther; 2010; 23(1):94-7. PubMed ID: 20136914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.
    Arbouw ME; Movig KL; Koopmann M; Poels PJ; Guchelaar HJ; Egberts TC; Neef C; van Vugt JP
    Neurology; 2010 Apr; 74(15):1203-7. PubMed ID: 20385892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
    Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of suspected symptomatic cholelithiasis with glycopyrrolate: a prospective, randomized clinical trial.
    Antevil JL; Buckley RG; Johnson AS; Woolf AM; Thoman DS; Riffenburgh RH
    Ann Emerg Med; 2005 Feb; 45(2):172-6. PubMed ID: 15671975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
    Stracke H; Gaus W; Achenbach U; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):600-5. PubMed ID: 18473286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gustatory sweating and diabetes mellitus.
    Tandon R; Bajpai HS
    J Assoc Physicians India; 1990 Dec; 38(12):953. PubMed ID: 2096142
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A.
    Eckardt A; Kuettner C
    Head Neck; 2003 Aug; 25(8):624-8. PubMed ID: 12884344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
    Paller AS; Shah PR; Silverio AM; Wagner A; Chamlin SL; Mancini AJ
    J Am Acad Dermatol; 2012 Nov; 67(5):918-23. PubMed ID: 22405644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of the sweating deficiency in diabetes mellitus.
    Kennedy WR; Sakuta M; Sutherland D; Goetz FC
    Ann Neurol; 1984 May; 15(5):482-8. PubMed ID: 6732196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report.
    Valensi P; Le Devehat C; Richard JL; Farez C; Khodabandehlou T; Rosenbloom RA; LeFante C
    J Diabetes Complications; 2005; 19(5):247-53. PubMed ID: 16112498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol in hypoglycaemia unawareness.
    Chalon S; Berlin I; Sachon C; Bosquet F; Grimaldi A
    Diabetes Metab; 1999 Mar; 25(1):23-6. PubMed ID: 10335420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
    J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Frey's syndrome with topical 2% diphemanil methylsulfate (Prantal): a double-blind evaluation of 15 patients.
    Laccourreye O; Bonan B; Brasnu D; Laccourreye H
    Laryngoscope; 1990 Jun; 100(6):651-3. PubMed ID: 2190054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A unique pattern of hyperhidrosis.
    Lewis VJ; Holt PJ
    Arch Dermatol; 2006 Feb; 142(2):264. PubMed ID: 16490867
    [No Abstract]   [Full Text] [Related]  

  • 38. Bilateral gustatory sweating as a sign of diabetic neuropathy.
    Mealey BL
    Oral Surg Oral Med Oral Pathol; 1994 Feb; 77(2):113-5. PubMed ID: 8139825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of oral glycopyrronium bromide in hyperhidrosis.
    Bajaj V; Langtry JA
    Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unilateral mydriasis due to a topical "anti-sweat" preparation.
    Johnson C; Smereck J
    J Emerg Med; 2013 Mar; 44(3):673-4. PubMed ID: 23158696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.